|
⚲
|
| Keyboard |
| Fairmount Healthcare Fund GP LLC
✚
|
|
|---|---|
| CIK # | 0001830383 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001830383] | |
| 4 | [0001830383] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Miragen Therapeutics Inc VRDN
Series A Non-Voting Convertible Preferred Stock · derivative
|
2024-03-28 | Other | 21,999 | $0.00 | |
|
Miragen Therapeutics Inc VRDN
Series A Non-Voting Convertible Preferred Stock · derivative
|
2024-03-28 | Other | 21,999 | $0.00 | |
|
Miragen Therapeutics Inc VRDN
Common Stock
|
2024-03-28 | Other | 5,859 | ||
|
Miragen Therapeutics Inc VRDN
Common Stock
|
2024-03-28 | Other | 5,859 | ||
|
Miragen Therapeutics Inc VRDN
Common Stock
|
2024-01-22 | Buy | 476,190 | $21.00 | 9,999,990 |
|
Miragen Therapeutics Inc VRDN
Series B Non-Voting Convertible Preferred Stock · derivative
|
2023-10-30 | Grant | 48,463 | $825.37 | 39,999,906 |
|
Miragen Therapeutics Inc VRDN
Common Stock
|
2022-08-17 | Buy | 425,531 | $23.50 | 9,999,978 |
|
Miragen Therapeutics Inc VRDN
Common Stock
|
2021-09-21 | Buy | 909,000 | $11.00 | 9,999,000 |
|
Miragen Therapeutics Inc MGEN
Series A Non-Voting Convertible Preferred Stock · derivative
|
2020-10-30 | Buy | 5,494 | $465.96 | 2,559,984 |
|
Miragen Therapeutics Inc MGEN
Series A Non-Voting Convertible Preferred Stock · derivative
|
2020-10-30 | Buy | 28,843 | $465.96 | 13,439,684 |
|
Miragen Therapeutics Inc MGEN
Series A Non-Voting Convertible Preferred Stock · derivative
|
2020-10-27 | Other | 16,505 | ||
|
Miragen Therapeutics Inc MGEN
Series A Non-Voting Convertible Preferred Stock · derivative
|
2020-10-27 | Other | 82,349 | ||
|
Miragen Therapeutics Inc MGEN
Common Stock
|
2020-10-27 | Other | 438,502 | ||
|
Miragen Therapeutics Inc MGEN
Common Stock
|
2020-10-27 | Other | 87,891 |